BJ
CDTX

BlackRock Japan’s Cidara Therapeutics CDTX Stock Holding History

BlackRock Japan’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$12K Hold
58
– – ﹤0.01% 1192
2016
Q3 		$13K Buy
58
+8
+16% +$1.85K ﹤0.01% 1179
2016
Q2 		$10K Sell
50
-12
-19% -$2.9K ﹤0.01% 1274
2016
Q1 		$16K Buy
+62
New +$14.3K ﹤0.01% 1212

Other funds holding CDTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Japan's CDTX Position: Q4 2016 in Review

BlackRock Japan held its Cidara Therapeutics (CDTX) position steady in Q4 2016 at 58 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

BlackRock Japan first reported a position in CDTX in Q1 2016 and has held it in 4 quarters since. The position peaked at $16K in Q1 2016. 58 funds tracked by Wall St. Rank hold CDTX as of Q4 2016.

  • BlackRock Japan held 58 shares of Cidara Therapeutics worth $12K as of Q4 2016.
  • BlackRock Japan left its Cidara Therapeutics share count unchanged in Q4 2016.
  • Cidara Therapeutics made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1192 holding.
  • BlackRock Japan first reported a position in Cidara Therapeutics in Q1 2016 and has held it in 4 quarters since.
  • BlackRock Japan's Cidara Therapeutics position peaked at $16K in Q1 2016.
  • 58 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.